 LAKEWOOD, Colo., Sept. 14, 2021 GLOBE NEWSWIRE -- Mesa Laboratories, Inc. NASDAQ:MLAB we, us, our, Mesa or the Company, a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, announced today that it has entered into a definitive agreement to acquire Agena Bioscience, Inc. Agena for a cash purchase price of 300 million, subject to customary purchase price adjustments. 